Us Pfizer Doses

Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.

An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.

People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.

Vaccination with two doses of the Pfizer jab stays highly effective against severe Covid -- including the Delta variant -- for at least six months, an analysis of US patients said Monday.

A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.

A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.

A third dose of the Pfizer Inc.-BioNTech SE Covid vaccine can dramatically reduce rates of Covid-related illness in people 60 and older, according to data from a short-term study in Israel.

COVID-19 antibodies produced by the Pfizer vaccine decreased more than 80 per cent in senior nursing home residents and their caregivers six months after receiving their second dose, a US study has found.

The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer coronavirus vaccine to some of the world's poorest countries, it said on Thursday, urging other G7 nations to follow suit.

The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.

Delhi Chief Minister Arvind Kejriwal today said Pfizer and Moderna have "refused to sell vaccines" to the state government. "They've told us they will talk to the central government," Mr Kejriwal said.

Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.

US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.

An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.

People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.

Vaccination with two doses of the Pfizer jab stays highly effective against severe Covid -- including the Delta variant -- for at least six months, an analysis of US patients said Monday.

A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.

A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.

A third dose of the Pfizer Inc.-BioNTech SE Covid vaccine can dramatically reduce rates of Covid-related illness in people 60 and older, according to data from a short-term study in Israel.

COVID-19 antibodies produced by the Pfizer vaccine decreased more than 80 per cent in senior nursing home residents and their caregivers six months after receiving their second dose, a US study has found.

The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer coronavirus vaccine to some of the world's poorest countries, it said on Thursday, urging other G7 nations to follow suit.

The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.

Delhi Chief Minister Arvind Kejriwal today said Pfizer and Moderna have "refused to sell vaccines" to the state government. "They've told us they will talk to the central government," Mr Kejriwal said.